日本三级美女_伦乱在线_999国内精品永久免费视频_国产精品嫩草影视_美女床上运动_性69无遮挡免费视频

       We focus on building a full-life cycle management service system for drugs with MAH (Marketing Authorization Holder) as the core and provide complete professional and public services for MAH product realization and clinical use through the way of “investment + platform” to ensure maximum value of MAH products. We have established Liangjiang Medicine, Liujiang Pharma, Lanjiang Pharmaceutical to carry out pharmacological research and Gerui Clinical Research Center to carry out clinical research in order to build CRO+GCP integrated service capability; we have built Dinglian API Production Base and Jinfeng Preparations Production Base to build CMO service capability; meanwhile, we have formed a sound product trading service system around domestic and overseas markets.

       We have spent more than ten years to build a one-stop CRO service platform covering drug discovery, pharmacological research, clinical research, drug registration and post-marketing research of drugs and have jointly built a Phase BE/I clinical research center which meets the CFDA-GCP standard with "Chongqing Mental Health Center" and "Chongqing Eleventh People’s Hospital".

Chongqing Gerui Clinical Research Center Co., Ltd

View details +

It was awarded “New Enterprise R&D Organization” by Chongqing Economic and Information Commission

Changchun Lanjiang Pharmaceutical Technology Co., Ltd.

View details +

Established in January 2019, located in Beihu Science Park of Changchun New Area (National New Area), Changchun Lanjiang Pharmaceutical Technology Co., Ltd. is a pharmaceutical technology company dedicated to pharmaceutical new product R&D, new drug technology development and transfer, and pharmacy technology services. It’s also the first pharmaceutical research company with MAH established in Jilin Province.